{"a": [["Report of the Expert Committee on the Diagnosis and Classification of diabetes mellitus", "1997"], ["The effect of the insulin analog lispro on night time blood glucose control in type 1 diabetic patients", "1998"], ["Safety and efficacy of [Lys(B28), Pro(29)]\u2010human insulin in patients with diabetes mellitus", "1997"], ["Insulintherapie in der Praxis", "2001"], ["Insulin analogues and their potential in the management of diabetes mellitus", "1999"], ["Validation of a diabetes\u2010specific quality of life scale for patients with type 1 diabetes", "1998"], ["Measures of psychological well\u2010being and treatment satisfaction developed from the responses of people with tablet\u2010treated diabetes", "1990"], ["A guide to psychological measurement in diabetes research and practice", "1994"], ["Meta\u2010analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes", "1998"], ["Post\u2010prandial administration of the insulin analogue insulin aspart in patients with Type 1 diabetes mellitus", "2000"], ["A coefficient of agreement for nominal scales", "1960"], ["Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta\u2010analysis", "2003"], ["Fear of hypoglycemia: quantification, validation and utilization", "1987"], ["Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II diabetes", "2002"], ["Meta\u2010analysis combining parallel and cross\u2010over clinical trials I:continuous outcomes", "2002"], ["Clinical outcomes with insulin lispro compared with human regular insulin: a meta\u2010analysis", "1997"], ["Reliability and validity of a diabetes quality\u2010of\u2010life for the diabetes control and complications trial", "1988"], ["Epidemiology of severe hypoglycemia in the diabetes control and complications Trial", "1991"], ["The effect of intensive treatment of diabetes on the development and progression of long\u2010term complications in insulin\u2010dependent diabetes mellitus", "1993"], ["Meta\u2010analysis involving cross\u2010over trials: methological issues", "2002"], ["Evidence\u2010based diabetes care", "2001"], ["Insulin\u2010like growth factor I acts as an angiogenic agent in rabbit cornea and retina: comparative studies with basic fibroblast growth factor", "1993"], ["The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease", "1998"], ["Do insulin\u2010treated diabetic patients use an injection\u2010meal\u2010interval in daily life?", "1995"], ["Time\u2010action profile of the insulin analogue B28Asp", "1996"], ["Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]", "2005"], ["Comparison of insulin aspart and lispro", "2003"], ["[Lys(B28),Pro(B29)]\u2010human insulin A rapidly absorbed analogue of human insulin", "1994"], ["Assessing the quality of reports of randomized clinical trials: is blinding necessary?", "1996"], ["Carciogen effect of the human insulin analogue B10 Asp in female rats", "1992"], ["Treatment of type 1 diabetes with insulin lispro during Ramadan", "2001"], ["Receptors and growth\u2010promoting effects of insulin and insulin\u2010like growth factors on cells from bovine retinal capillaries and aorta", "1985"], ["Correlation of receptor binding and metabolic and metogenic potencies of insulin analogues designed for clinical use", "2000"], ["The diabetes annual 12", "1999"], ["A short\u2010acting insulin analogue in clinical practice", "1994"], ["Modeling absorption kinetics of subcutaneous injected soluble insulin", "1989"], ["Risk factors of severe hypoglycaemia in adult patients with Type 1 diabetes \u2010 a prospective population based study", "1998"], ["A direct comparison of insulin aspart and insulin lispro in patients with type 1 diabetes", "2002"], ["The relationship between symptomatic and biochemical hypoglycemia in insulin\u2010dependent diabetic patients", "1990"], ["Reducing snacks when switching from conventional soluble to lispro insulin treatment: Effects on glycaemic control and hypoglycaemia", "1998"], ["Postprandial insulin lispro: a new therapeutic option for type 1 diabetic patients", "1998"], ["Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials", "1995"], ["Insulin lispro: A critical evaluation", "1999"], ["Pharmacokinetics, pharmacodynamics and glucose counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28),Pro(B29)] in IDDM", "1994"], ["Diabetes mellitus. Report of a WHO Study Group", "1985"], ["The physiological replacement of insulin: An elusive goal", "1989"]], "ex": [["Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: Experience with insulin lispro", "2000"], ["Long\u2010term efficacy and safety of biphasic insulin aspart in patients with type 2 diabetes", "2004"], ["Improvement of blood glucose control in type 1 diabetic patients treated with lispro and multiple NPH injections", "1999"], ["Pregnancy complications and perinatal outcome in diabetic women treated with Humalog (insulin lispro) or regular human insulin during pregnancy", "2004"], ["A randomized trial of insulin aspart with intensified basal NPH insulin supplementation in people with Type 1 diabetes", "2003"], ["Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin", "1996"], ["Pre\u2010meal insulin analogue insulin lispro vs humulin insulin treatment in young subjects with type 1 diabetes", "1996"], ["Impact of insulin lispro on HbA1c values in insulin pump users", "2000"], ["Does insulin lispro preserve the physiological defences to hypoglycaemia during intensive insulin therapy with a conventional basal bolus regimen?", "2002"], ["Basal\u2010bolus insulin therapy in type 1 diabetes: comparative study of pre\u2010meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin", "2002"], ["Optimized basal\u2010bolus therapy using a fixed mixture of 75% lispro and 25% NPL insulin in type 1 diabetes patients: No favorable effects on glycemic control, physiological responses to hypoglycemia, well\u2010being, or treatment satisfaction", "2000"], ["Improved glycemic control can be better maintained with insulin lispro than with human regular insulin", "1998"], ["Effects of mixing glargine and short\u2010acting insulin analogs on glucose control", "2004"], ["Use of insulin pump therapy at nighttime only for children 7\u201010 years of age with type 1 diabetes", "2000"], ["Starting patients with type 2 diabetes on insulin therapy using once\u2010daily injections of biphasic insulin aspart 70/30, biphasic insulin 70/30, or NPH insulin combination with metformin", "2003"], ["Efficacy and safety of continuous subcutaneous insulin infusion using Lispro analog in treatment of patients with new diagnosed type 1 diabetes", "2001"], ["Long\u2010term intensive treatment of type 1 diabetes with the short\u2010acting insulin analog lispro in variable combination with NPH insulin at mealtime", "1999"], ["Experience with Lispro\u2010insulin in the intensified therapy of IDDM and NIDDM patients", "1996"], ["Glycemic control in obese insulin\u2010resistant type 2 diabetic patients treated with insulin lispro", "2001"], ["Efficacy of humalog injections before an afternoon meal and their acceptance by children and adolescents with type 1 diabetes", "2002"], ["Twice\u2010daily biphasic insulin aspart 30 versus biphasic hunam insulin 30: a double\u2010blind crossover study in adults with type 2 diabetes mellitus", "2002"], ["Improvement of HbA1c and blood glucose stability in IDDM patients treated with lispro insulin analog in external pumps", "1998"], ["Long\u2010term comparison of human insulin analogue B10Asp and soluble human insulin in IDDM patients on a basal/bolus insulin regimen", "1995"], ["Intensive insulin therapy in type II diabetic patients. Comparison of regular insulin and a rapidly acting insulin analogue", "1995"], ["Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes", "1996"], ["Improved glycemic control with the use of self\u2010prepared mixtures of insulin lispro and insulin lispro protamine suspension in patioents with types 1 and 2 diabetes", "2001"], ["Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes", "2003"], ["Metabolic control in patients with type 2 diabetes using humalog mix 50 injected three times daily: crossover comparison with human insulin 30/70", "2004"], ["Glycaemic control in type 1 diabetic patients using optimised insulin aspart or human insulin in a randomised multinational study", "2001"], ["Counterregulatory hormone responses after long\u2010term continuous subcutaneous insulin infusion with lispro insulin", "1998"], ["Lispro insulin treatment in comparison with regular human insulin in Type 2 diabetic patients living in nursing homes", "2002"]], "in": [["Comparison of additional metformin or NPH insulin to mealtime insulin lispro therapy with mealtime human insulin therapy in secondary OAD failure", "2003"], ["Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non\u2010insulin\u2010dependent diabetes mellitus", "1997"], ["Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin\u2010analog treatment. Multicenter Insulin Lispro Study Group", "1997"], ["Improved mealtime treatment of diabetes mellitus using an insulin analogue. Multicenter Insulin Lispro Study Group", "1997"], ["Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial", "2001"], ["Efficacy, safety, and pump compatibility of insulin aspart used in continuous subcutaneous insulin infusion therapy in patients with type 1 diabetes", "2001"], ["Comparison of insulin aspart with buffered regular insulin and insulin lispro in continuous subcutaneous insulin infusion", "2002"], ["Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in type 1 and type 2 diabetic patients", "2002"], ["Effect of the rapid\u2010acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes", "2003"], ["A direct efficacy and safety of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes", "2004"], ["Effect of insulin lispro on glycaemic control in chinese diabetic patients receiving twice\u2010daily regimens of insulin", "2004"], ["Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime", "1999"], ["Insulin lispro lowers postprandial glucose in prepubertal children with diabetes", "2001"], ["Use of the short\u2010acting insulin analogue lispro in intensive treatment of type 1 diabetes mellitus: Importance of appropriate replacement of basal insulin and time\u2010interval injection\u2010meal", "1998"], ["Severe hypoglycaemia in patients with type 1 diabetes and impaired awareness of hypoglycaemia: a comparative study of insulin lispro and regular human insulin", "2001"], ["Insulin lispro: a potential role in preventing nocturnal hypoglycaemia in young children with diabetes mellitus", "2003"], ["A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy", "2000"], ["The effect of improved post\u2010prandial blood glucose control on post\u2010prandial metabolism and markers of vascular risk in people with type 2 diabetes", "2005"], ["Optimal basal bolus insulin in type 1 diabetes: insulin glulisine insulin versus regular human insulin in combination with basal insulin glargine", "2005"], ["Treatment with insulin lispro changes the insulin profile but does not affect the plasma concentrations of IGF\u2010I and IGFBP\u20101 in type 1 diabetes", "2001"], ["Effect of the fast\u2010acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy", "1999"], ["Hypoglycaemia with insulin aspart: a double\u2010blind, randomised, cross over trial in subjects with tpye 1 diabetes", "2004"], ["Effects of a fixed mixture of 25% insulin lispro and 75% NPL on plasma glucose during and after moderate physical exercise in patients with type 2 diabetes", "2002"], ["Humalog Mix25 improves 24\u2010hour profiles compared with the human insulin mixture 30/70 in patients wioth type 2 diabetes mellitus", "2003"], ["Comparison of insulin lispro with regular human insulin for the treatment of type 1 diabetes in adolescents", "2002"], ["Reduced frequency of severe hypoglycemia and coma in well\u2010controlled IDDM patients treated with insulin lispro", "1997"], ["Improved glycemic control with insulin aspart: a multicenter randomized double\u2010blind crossover trial in type 1 diabetic patients", "1998"], ["Insulin aspart vs. human insulin in the management of long\u2010term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial", "2000"], ["Comparison between insulin aspart and soluble human insulin in type 1 diabetes (IDDM) patients treated with basal\u2010bolus insulin therapy \u2010 Phase III clinical trial in Japan", "2001"], ["Metabolic efficacy of preprandial administration of Lys(B28),Pro(B29) human insulin analog in IDDM patients", "1997"], ["Improved blood glucose variability, HBA1C Insuman Infusat and less insulin requirement in IDDM patients using insulin lispro in CSII. The Swedish multicenter lispro insulin study", "2000"], ["Metabolic and immunologic effects of insulin lispro in gestational diabetes", "1999"], ["Health\u2010related quality\u2010of\u2010life results from multinational clinical trials of insulin lispro", "1997"], ["Maternal metabolic control and perinatal outcome in women with gestational diabetes treated with regular or lispro insulin: comparison with non\u2010diabetic pregnant women", "2003"], ["Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus", "2002"], ["Lispro insulin in Type 1 diabetic patients on a mediterranean or normal diet: A randomized, cross\u2010over comparative study with regular insulin", "2001"], ["Use of insulin aspart, a fast\u2010acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes", "2000"], ["A comparison of insulin lispro and buffered regular human insulin administered via continuous subcutaneous insulin infusion pump", "2001"], ["Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving \u00df\u2010cell function at onset of type 1 diabetes mellitus", "2003"], ["Use of insulin lispro in continuous subcutaneous insulin infusion treatment", "1999"], ["Improved postprandial blood glucose control and reduced nocturnal hypoglycemia during treatment with two novel insulin lispro\u2010protamine formulations, insulin lispro Mix25 and insulin lispro Mix50", "1999"], ["Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine\u2010based insulin lispro formulation", "1999"], ["A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents", "2001"], ["Human insulin analogue [LYS(B28), PRO(B29)]: the ideal pump insulin?", "1998"], ["Insulin lispro improves postprandial glucose control in patients with diabetes mellitus", "2002"], ["Special management of insulin lispro in continuous subcutaneous insulininfusion in young diabetic children: a randomized cross\u2010over study", "2004"], ["Post\u2010prandial insulin lispro vs. human regular insulin in prepubertal children with Type 1 diabetes mellitus", "2001"], ["Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin\u2010dependent or non\u2010insulin\u2010dependent diabetes", "1997"], ["Insulin lispro in CSII: Results of a double\u2010blind crossover study", "1997"]]}